Core Oncology Ltd was founded in 2010 by Irene Gow to support early phase oncology drug development by biopharmaceutical companies, CRO’s and research physicians.
Decades of experience working in biotech, pharmaceutical and CRO environments – taking drugs from bench to bedside – have highlighted important gaps and areas for improvement in the oncology drug development space.
Core Oncology now leverages this experience to provide drug development companies with flexible protocol development design, key opinion leader liaison, clinical program development and rapid response trial feasibility services. Core Oncology has a proven track record of saving time and money for its clients and delivering quantifiable improvements in timelines and outcomes.
Core Oncology also works closely with research physicians to identify relevant clinical studies and to simplify the feasibility questionnaire process.